Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Year End Accounts and Preliminary Final Report

28 August 2015 by Justine Bednorz

Year End Accounts and Preliminary Final Report

Categories 2015, ASX Announcements
Presentation to Investors
Interim Data from BIT225-008 Study in Subjects with Hepatitis C Virus Genotype 3
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 24 April 2025        Legal Notices and Privacy
Cleantalk Pixel